Samsung Becomes Largest Shareholder in U.S. Gene Sequencing Firm, Targeting Precision Medicine Market

Samsung Electronics has joined as a strategic investor in Element Biosciences, a U.S.-based genetic analysis equipment company, securing the position of its largest shareholder through a Series E funding round.